Plain-English translation of NCT06104852 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This is a screening survey designed to help researchers identify people who might be good candidates for Alzheimer's disease clinical trials. The study will collect information about your health, medications, and medical history to understand what types of patients are seeking to participate in research. This information helps researchers prepare future studies and understand potential barriers to enrollment.
Many people with Alzheimer's want to participate in clinical trials, but researchers need better information about this population. Understanding which medications patients are taking and what health factors might exclude them from trials can help design better and more inclusive studies in the future.
You likely qualify if…
You likely don't qualify if…
Your participation would primarily involve completing a survey about your health history, current medications, and other medical information. You may also have some basic tests or lab work to help researchers understand your eligibility for future trials. The exact timeline and number of visits isn't specified, but this type of screening survey is typically straightforward and designed to take a reasonable amount of your time.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States
Sponsor
Adams Clinical
Enrollment target
~600 participants
Started
June 2023
Primary completion
June 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in October 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Sarah J Starling, PhD
Adams Clinical
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.